[Federal Register Volume 60, Number 176 (Tuesday, September 12, 1995)]
[Notices]
[Pages 47393-47395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-22588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Announcement 602]
Public Health Conference Support Cooperative Agreement Program
for Human Immunodeficiency Virus (HIV) Prevention
Introduction
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1996 funds for the Public Health
Conference Support Cooperative Agreement Program for Human
Immunodeficiency Virus (HIV) Prevention. The Public Health Service
(PHS) is committed to achieving the health promotion and disease
prevention objectives of Healthy People 2000, a PHS-led national
activity to reduce morbidity and mortality and improve the quality of
life. This announcement is related to the priority area of HIV
Infection. (To order a copy of ``Healthy People 2000'' or CDC's
``Strategic Plan for Preventing Human Immunodeficiency Virus (HIV)
Infection'' (July 8, 1992), see the Section ``Where to Obtain
Additional Information.'')
Authority
This program is authorized under sections 301 (42 U.S.C. 241) and
310 (42 'U.S.C. 242n) of the Public Health Service Act, as amended.
Applicable program regulations are found in 42 CFR part 52--Grants for
Research Projects.
Smoke-Free Workplace
The Public Health Service strongly encourages all grant recipients
to provide a smoke-free workplace and promote the non-use of all
tobacco products, and Pub. L. 103-227, the Pro- Children Act of 1994,
prohibits smoking in certain facilities that receive Federal funds in
which education, library, day care, health care, and early childhood
development services are provided to children.
Eligible Applicants
Eligible applicants are non-governmental, nonprofit and for-profit
organizations. Thus, universities, colleges, research institutions,
hospitals, other public and private (e.g., national, regional)
organizations, federally recognized Indian tribal governments, Indian
tribes or Indian tribal organizations, and small, minority- or women-
owned businesses are eligible for these cooperative agreements. Current
recipients of CDC HIV funding must provide the award number and title
of the program (see the Section ``Program Requirements, C. Letter of
Intent'').
Availability of Funds
Up to $250,000 may be available in FY 1996 to fund approximately 10
to 15 awards. The awards will average $20,000 and will be funded for a
12-month budget and project period. The funding estimate may vary and
is subject to change, based on availability of funds. Awards will
initially be made on a contingency basis as described in the Purpose
section.
The following are examples of the most frequently encountered costs
that may or may not be charged to the cooperative agreement:
1. As approved, CDC funds may be used for direct cost expenditures:
salaries, speaker fees, rental of conference related equipment,
registration fees, and transportation cost (not to exceed economy class
fares) for non-Federal employees.
2. CDC funds may not be used for the purchase of equipment,
payments of honoraria, organizational dues, entertainment or personal
expenses, cost of travel and payment of a full-time Federal employee,
or per diem or expenses, other than mileage, for local participants.
3. CDC funds may not be used for reimbursement of indirect costs.
4. Although the practice of handing out novelty items at meetings
is often employed in the private sector to provide participants with
souvenirs, Federal funds may not be used for this purpose.
5. CDC funds may be used for only those parts of the conference
specifically supported by CDC as documented in the Notice of
Cooperative Agreement (award document).
Recipient Financial Participation
Part of the cost of the proposed conference must be funded by other
than CDC funds.
Purpose
The purpose of the HIV prevention conference support cooperative
agreement is to provide partial support for non-Federal conferences or
specified portions of non-Federal conferences to stimulate efforts to
prevent the transmission of HIV. CDC will collaborate on conferences
that specifically focus on preventing HIV transmission. Because
conference support by CDC creates the appearance of CDC co-sponsorship,
CDC will actively participate in the development and approval of those
portions of the agenda supported by CDC funds. Contingency awards will
be made allowing usage of only 25% of the total amount to be awarded
until a final full agenda is approved by CDC. This will provide funds
for costs associated with preparation of the agenda. The remainder of
funds will be released only upon acceptance of the final full agenda.
CDC reserves the right to terminate co-sponsorship if it does not
approve the final agenda.
Program Requirements
CDC will provide support for conferences that are:
1. Regional (more than one State), national, or international in
scope;
2. Targeted to professionals contributing to HIV prevention
efforts; and
3. Focused on the transfer of HIV prevention research and
evaluation findings to intervention efforts or the application of these
prevention efforts to service providers and health professionals who
provide service to individuals whose behaviors place them at increased
risk for HIV infection.
Topics concerned with issues and areas other than HIV prevention
should be directed to other public health agencies or in accordance
with current Federal Register Notices (see Federal Register Notice 600,
April 20, 1995, 60 FR 19750).
The activities related to the development of HIV prevention
conferences require substantial CDC collaboration and involvement. In
conducting activities to achieve the purpose of the program, the
recipient shall be responsible for conducting activities listed in
section A., and CDC will be responsible for conducting activities
listed in section B.:
A. Recipient Activities
1. Manage all activities related to program content (e.g.,
objectives, topics, participants, session design, workshops, special
exhibits, speakers, fees, agenda composition, and printing). Many of
[[Page 47394]]
these items may be developed in concert with assigned CDC project
personnel.
2. Provide draft copies of the agenda and proposed ancillary
activities to the CDC program office for review and comment. Submit a
copy of the final agenda and proposed ancillary activities to the CDC
Grants Management Office for acceptance.
3. Determine and manage all promotional activities (e.g., title,
logo, announcements, mailers, press). CDC must review and approve the
use of any materials with reference to CDC involvement or support.
4. Manage all registration processes with participants, invitees,
and registrants (e.g., travel, reservations, correspondence, conference
materials and hand-outs, badges, registration procedures).
5. Plan, negotiate, and manage conference site arrangements,
including all audiovisual needs.
6. Develop and conduct education and training programs on HIV
prevention.
7. Collaborate with CDC staff in reporting and disseminating
results and relevant HIV prevention education and training information
to appropriate Federal, State, and local agencies, health-care
providers, HIV/AIDS prevention and service organizations, and the
general public.
B. CDC Activities
1. Provide technical assistance through telephone calls,
correspondence, and site visits in the areas of program agenda
development, implementation, and priority setting related to the
cooperative agreement.
2. Provide scientific collaboration for appropriate aspects of the
program, including selection of speakers, pertinent scientific
information on risk factors for HIV infection, preventive measures, and
program strategies for the prevention of HIV infection.
3. Review draft agendas and approve the final agenda and proposed
activities prior to release of restricted funds.
4. Assist in the reporting and dissemination of research results
and relevant HIV prevention education and training information to
appropriate Federal, State, and local agencies, health-care providers,
the scientific community, and HIV/AIDS prevention and service
organizations, and the general public.
C. Letter of Intent
Respondents must submit a one-page, typewritten letter of intent
(LOI) that briefly describes the title, location, and purpose of the
meeting, its relationship to the following described CDC Topics of
Special Interest, the date of the proposed conference, and the intended
audience (number and description). No attachments, booklets, or other
documents accompanying the LOI will be considered. The letter should
also include the estimated total cost of the conference and the
percentage of the total cost (which must be less than 100%) being
requested from CDC. Current recipients of CDC HIV funding must provide
the award number and title of the funded programs. LOIs will be
reviewed by CDC program staff, and an invitation to submit an
application will be made based on the proposed conference's
relationship to the CDC topics of special interest and the availability
of funds. An invitation to submit an application does not constitute a
commitment by CDC to fund the applicant.
D. Topics of Special Interest
Funding preferences are established to ensure a balance of CDC HIV
prevention funding and to address at-risk populations that are
underserved. CDC is especially interested in supporting meetings and
conferences for HIV prevention service providers on the following
topics:
1. Prevention of HIV infection among:
a. Underserved populations (e.g., women of reproductive age, racial
and ethnic minorities);
b. High-risk populations, including both in-school and out-of-
school youth; or
c. Populations in special settings (e.g., racial and ethnic
minorities; out-of-school, high-risk youth; incarcerated persons; men
who have sex with men; high-risk drug users; and migrant workers).
Particular attention will be given to organizations that serve multiple
high-risk populations.
2. Development of HIV prevention strategies with a broad range of
community partners including those who have not traditionally been
involved with public health programs (e.g., business, religious
leaders).
3. Development of prevention marketing strategies, including
various behavior modification messages related to sex practices (e.g.,
abstinence, condom use).
Note: To provide for adequate time to collaborate on the meeting
agenda and content, applicants should allow a minimum of 3 months
from the scheduled application due date to the planned date of the
conference. (See the Section Letter of Intent and Application
Submission and Deadlines.) Meetings scheduled to begin earlier than
March 15, 1996, will not be routinely considered for funding.
Evaluation Criteria
LOIs will be reviewed by CDC program staff for consistency with
CDC's HIV prevention goals and priorities and the purposes of this
program. An invitation to submit an application will be made on the
basis of the proposed conference's relationship to the CDC determined
topics of special interest, the timing of the meeting or conference
that would allow for CDC input, and the availability of funds.
Applications will be reviewed and evaluated according to the following
criteria.
(Total points available is 100).
A. Proposed Program and Technical Approach: (50 Points)
Evaluation will be based on:
1. The applicant's description of the proposed conference as it
relates to HIV prevention and education, including the public health
need of the proposed conference and the degree to which the conference
can be expected to influence public health practices, and the extent of
the applicant's collaboration with other agencies serving the intended
audience, including local health and education agencies concerned with
HIV prevention.
2. The applicant's description of conference objectives in terms of
quality, specificity and the feasibility of the conference based on the
operational plan, and the extent to which evaluation mechanisms for the
conference adequately assess increased knowledge, attitudes, and
behaviors of the target participants.
3. The relevance and effectiveness of the proposed agenda in
addressing the chosen HIV prevention/education topic.
4. The degree to which conference activities proposed for CDC
funding strictly adhere to the prevention of HIV transmission.
B. Applicant Capability (25 Points)
Evaluation will be based on:
1. The adequacy and commitment of institutional resources to
administer the program.
2. The adequacy of existing and proposed facilities and resources
for conducting conference activities.
3. The degree to which the applicant has established and used
critical linkages with health and education agencies with the mandate
for HIV prevention. Letters of support from such agencies should be
obtained to demonstrate the linkages specific to the conference.
C. Qualifications of Program Personnel: (25 Points)
Evaluation will be based on:
[[Page 47395]]
1. The qualifications, experience, and commitment of the principal
staff person, and his/her ability to devote adequate time and effort to
provide effective leadership.
2. The competence of associate staff persons, discussion leaders,
and speakers to accomplish conference objectives.
3. The degree to which the application demonstrates that key
personnel have knowledge about the transmission of HIV, and current
nationwide information and education efforts that may affect, and be
affected by, the proposed conference.
D. Budget Justification and Adequacy of Facilities: (Not Scored)
The proposed budget will be evaluated on the basis of its
reasonableness, concise and clear justification, consistency with the
intended use of cooperative agreement funds, and the extent to which
the applicant documents financial support from other sources.
Executive Order 12372 Review
This program is not subject to the Executive Order 12372 review.
Public Health System Reporting Requirements
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance
The Catalog of Federal Domestic Assistance number is 93.118,
Acquired Immunodeficiency Syndrome (AIDS) activities.
Other Requirements
Recipients must comply with the document entitled Content of HIV/
AIDS-Related Written Materials, Pictorials, Audiovisuals,
Questionnaires, Survey Instruments, and Educational Sessions in Centers
for Disease Control Assistance Programs (June 1992) (a copy is in the
application kit). To meet the requirements for a Program Review Panel,
recipients are encouraged to use an existing Program Review Panel such
as the one created by the State health department's HIV/AIDS prevention
program. If the recipient forms its own Program Review Panel, at least
one member must also be an employee (or a designated representative) of
an appropriate health or educational agency, consistent with the
revised Content Guidelines. The names of review panel members must be
listed on the Assurance of Compliance form (CDC Form 0.1113) which is
also included in the application kit.
Letter of Intent and Application Submission and Deadlines
The original and two copies of the LOI must be postmarked by the
October 13, 1995, deadline date to be considered. Within four weeks,
successful respondents will receive a written request to submit an
application for funding; unsuccessful respondents will be also be
notified in writing. A request to submit an application does not
constitute a commitment to fund the applicant.
The original and two copies of the application must be submitted on
PHS Form 5161-1 (OMB Number 0937-0189) by December 22, 1995. The
earliest possible award date is February 16, 1996, and the earliest
possible conference date is March 15, 1996. Applications must be
postmarked on or before the deadline date and sent to Clara M. Jenkins,
Grants Management Officer, Grants Management Branch, Procurement and
Grants Office (Ann. #602), Centers for Disease Control and Prevention
(CDC), MS E-15, 255 East Paces Ferry Road, NE., Room 320, Atlanta, GA
30305.
Deadlines
The Letter of Intent and requested applications shall be considered
as meeting the applicable deadline if they are either:
A. Received on or before the deadline date, or
B. Postmarked on or before the deadline date (respondents should
request a legibly dated U.S. Postal Service postmark or obtain a
legibly dated receipt from a commercial carrier or the U.S. Postal
Service. Private metered postmarks will not be acceptable as proof of
timely mailing.)
Where To Obtain Additional Information
To receive additional written information, call (404) 332-4561. You
will be asked to leave your name, address, and phone number, and will
need to refer to Announcement Number 602. You will receive a copy of
the program announcement, a list of the relevant Healthy People 2000
HIV objectives, and the addresses and phone numbers for CDC contact
personnel. The announcement is also available through the CDC homepage
on the Internet. The address for the CDC homepage is http://
www.cdc.gov. CDC will not send application kits by facsimile or express
mail unless the cost for the latter is paid by the addressee.
If you have questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from Mr. Kevin Moore, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 320, Atlanta, GA
30305, telephone (404) 842-6550. Programmatic technical assistance may
be obtained from Ms. Linda LaChanse, Program Analyst, Training and
Technical Services Support Branch, Division of HIV/AIDS Prevention,
National Center for HIV/STD/TB Prevention, Centers for Disease Control
and Prevention (CDC), 1600 Clifton Road, NE., Mailstop E-40, Atlanta,
GA 30333, telephone (404) 639-2918. Please refer to Announcement Number
602 when requesting information and when submitting your application in
response to the announcement.
Respondents may obtain a copy of Healthy People 2000 (Full Report,
Stock No. 017-001-00474-0) or Healthy People 2000 (Summary Report,
Stock No. 017-001-00473-1) through the Superintendent of Documents,
Government Printing Office, Washington, DC 20402-9325, telephone (202)
512-1800. Single copies of CDC's Strategic Plan for Preventing Human
Immunodeficiency Virus (HIV) Infection (July 8, 1992) can be obtained
by calling the CDC National AIDS Clearinghouse at (800) 458-5231.
Dated: September 5, 1995.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 95-22588 Filed 9-11-95; 8:45 am]
BILLING CODE 4163-18-P
